Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
BIL also holds an option to increase its equity stake by an additional 15%
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
Subscribe To Our Newsletter & Stay Updated
